Wearable device for Parkinson’s disease raises $10m in funding


Author: Sarah McGrathPublished: 25 November 2021

Parkinson's LifePrep: Parkinson's LifeCook: Parkinson's LifeServes:

A person holds the CUE1 medical device.

UK-based tech company Charco Neurotech has secured $10 million in seed investment funding to support the launch of a non-invasive wearable device designed for people with Parkinson’s disease.

CUE1 is a circular device worn on the sternum, which is designed to help alleviate Parkinson’s symptoms through specialised vibrations that are personalised for each patient.

The investment round, which was co-led by venture capital company Amadeus Capital Partners and growth fund managers Parkwalk Advisors, is the largest European seed financing in 2021 for a heath technology device – and the sixth largest globally.

Lucy Jung, co-founder and CEO of Charco Neurotech, said: “This funding will enable us to proceed with our first, limited launch, while we work to ensure our manufacturing line is robust and produces consistent high quality devices.”

Charco also recently announced a new partnership with Parkinson’s Europe, to help increase the availability of Charco’s solutions for people with Parkinson’s around the world.

Read more:

Could a wearable device help ease Parkinson’s disease symptoms?

New wearable medical device for Parkinson’s disease to launch this year

Go Back

Share this story


Related articles

A woman ties her shoelaces, with a smartphone on the floor beside her.

Resources & Tools

Five more apps for people with Parkinson’s

Access Parkinson’s disease support on your smartphone



Could a wearable device help ease Parkinson’s disease symptoms?

We talk to the team behind the innovative CUE1 device


sponsored article


Deep Brain Stimulation for Parkinson’s disease just got smarter

Find out more about a new DBS innovation